Skip to main content
Signal8

COWARD D SCOTT

SEC insider (Form 3/4/5 filer). CIK 0001247296. Director at Humacyte, Inc. (HUMA) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Oct 6, 2026. Located in DURHAM, NC.

Companies COWARD D SCOTT has filed insider reports for

  • Humacyte, Inc. (HUMA): Director
  • EXACT SCIENCES CORP (EXAS): Director
COWARD D SCOTT profile photo

COWARD D SCOTT

CIK: 0001247296

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)4 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Humacyte, Inc. logo
HUMA

Humacyte, Inc.

Director
EXACT SCIENCES CORP logo
EXAS

EXACT SCIENCES CORP

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Oct 6, 2026
    Award

    Stock Options (right to buy)

    Direct
    125K shares-
  • EXACT SCIENCES CORP logo
    EXAS

    EXACT SCIENCES CORP

    Mar 23, 2026
    Disposition
    Direct
    52.2K shares-
  • EXACT SCIENCES CORP logo
    EXAS

    EXACT SCIENCES CORP

    Mar 23, 2026
    Disposition
    Direct
    5.4K shares-
  • EXACT SCIENCES CORP logo
    EXAS

    EXACT SCIENCES CORP

    Mar 23, 2026
    Disposition
    Indirect
    4.7K shares-
  • EXACT SCIENCES CORP logo
    EXAS

    EXACT SCIENCES CORP

    Jun 12, 2025
    Award
    Direct
    5.4K shares-
  • EXACT SCIENCES CORP logo
    EXAS

    EXACT SCIENCES CORP

    Feb 19, 2025
    Exercise
    Direct
    2.2K shares-
  • EXACT SCIENCES CORP logo
    EXAS

    EXACT SCIENCES CORP

    Feb 19, 2025
    Tax Payment
    Direct
    667 shares at avg. $49.63$33K
  • EXACT SCIENCES CORP logo
    EXAS

    EXACT SCIENCES CORP

    Jun 13, 2024
    Award
    Direct
    5.9K shares-

1-8 of 8